Empyema and bacteremic pneumococcal pneumonia in children under five years of age

Maria Regina Alves Cardoso1, Cristiana Maria Costa Nascimento-Carvalho2, Fernando Ferrero3

  • 1University of São Paulo School of Public Health, Department of Epidemiology, São Paulo, Brazil, Associate Professor. Department of Epidemiology, University of São Paulo School of Public Health, São Paulo, Brazil.

Insights

Distinguishing pneumococcal empyema (PE) from bacteremic pneumococcal pneumonia (BPP) in young children is possible through clinical and laboratory findings. Early diagnosis of these severe conditions is vital for better outcomes.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Pulmonology

Background:

  • Pneumococcal pneumonia and empyema are significant causes of childhood respiratory illness.
  • Bacteremic pneumococcal pneumonia (BPP) and pneumococcal empyema (PE) are distinct but related severe infections in children.

Purpose of the Study:

  • To compare clinical, radiological, and laboratory findings between BPP and PE in children under five.
  • To identify differentiating features to aid in the prompt diagnosis of these conditions.

Main Methods:

  • A cross-sectional nested cohort study was conducted across 12 centers in Argentina, Brazil, and the Dominican Republic.
  • The study included 102 children with PE and 128 children with BPP, all under the age of five.

Main Results:

  • Children with PE were older and had longer disease duration, with more frequent tachypnea, dyspnea, and elevated leukocyte counts.
  • Fever and lethargy were more common in children with BPP.
  • Clinical and laboratory findings appear to differentiate PE from BPP in this pediatric cohort.

Conclusions:

  • Clinical and laboratory presentations differ between PE and BPP in young children.
  • Prompt and accurate diagnosis is crucial for managing both conditions, which are associated with high morbidity and mortality.

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
24
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.5K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.4K
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
84
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
15
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
4.7K